文献速递角膜与眼表疾病

结膜自体移植与羊膜移植治疗翼状胬肉:Cochrane系统评价发现

Conjunctival Autograft Versus Amniotic Membrane Transplantation for Treatment of Pterygium: Findings From a Cochrane Systematic Review.
PubMed 文献 · Am J Ophthalmol · 2017-07-19

该Cochrane系统评价纳入20项随机对照试验共1866名参与者(1947眼),比较结膜自体移植(CAG)与羊膜移植(AMT)治疗原发或复发翼状胬肉的效果。Meta分析显示,术后6个月CAG组复发风险较AMT组降低47%(RR 0.53,95%CI 0.33-0.85);复发翼状胬肉亚组(96眼)中CAG组复发风险降低55%(RR 0.45,95%CI 0.21-0.99)。

要点

  • 术后6个月CAG组翼状胬肉复发风险较AMT组降低47%(RR 0.53,95%CI 0.33-0.85)。
  • 复发翼状胬肉患者中CAG组6个月复发风险较AMT组降低55%(RR 0.45,95%CI 0.21-0.99)。
  • 基于538眼(6项RCT)数据,CAG与AMT的3个月复发率相似。

核心结论

  • 术后6个月CAG在预防翼状胬肉复发方面比AMT更有效,尤其在复发翼状胬肉中。
  • CAG治疗眼的复发率约为AMT治疗眼的一半。

研究设计与样本

  • Cochrane系统评价,仅纳入比较CAG与AMT治疗原发或复发翼状胬肉的随机对照试验(RCT)。
  • 共纳入20项RCT,1866名参与者(1947眼)。
  • 主要结局为术后3个月和6个月翼状胬肉复发(复发定义为胬肉侵入角膜≥1 mm)。

主要发现

  • 基于10项RCT共1021眼数据,术后6个月复发率CAG组范围为3.3%至16.7%,AMT组范围为6.4%至42.3%。
  • Meta分析估计,术后6个月CAG治疗眼复发风险较AMT组降低47%(RR 0.53,95%CI 0.33-0.85)。
  • 在96眼复发翼状胬肉中,CAG术后6个月复发风险较AMT降低55%(RR 0.45,95%CI 0.21-0.99)。
  • 基于538眼(6项RCT)数据,CAG与AMT的3个月复发率相似。

局限性

  • 未来RCT应评估患者报告结局(症状、美观)和视力的变化,并评价手术方式变异的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To summarize key findings from a systematic review of the effectiveness and risks of conjunctival autograft (CAG) compared with amniotic membrane transplant (AMT) for pterygium. DESIGN: Cochrane systematic review. METHODS: We included only randomized controlled trials (RCTs) in which CAG and AMT had been compared for primary or recurrent pterygia. The primary outcome was recurrence of pterygium ≥1 mm onto the cornea by 3 and 6 months post surgery. We adhered to Cochrane methods for trial selection, data extraction, risk of bias evaluation, and data synthesis. RESULTS: Twenty RCTs with 1866 participants (1947 eyes) were included. Pterygium recurrence 6 months after surgery ranged from 3.3% to 16.7% in the CAG group and 6.4% to 42.3% in the AMT group based on data from 1021 eyes in 10 RCTs. Estimated risk ratios from meta-analysis indicated that CAG-treated eyes had a 47% lower risk of recurrence 6 months after surgery compared with the AMT group (RR, 0.53, 95% confidence interval [CI], 0.33-0.85). For 96 eyes with recurrent pterygium, the risk of recurrence 6 months after CAG was reduced by 55% compared with AMT (risk ratio [RR], 0.45, 95% CI, 0.21-0.99). Three-month recurrence rates were similar for CAG and AMT based on data from 538 eyes (6 RCTs). CONCLUSIONS: CAG was more effective than AMT to prevent pterygium recurrence by 6 months post surgery, especially in recurrent pterygia. CAG-treated eyes had half the recurrence rates of AMT-treated eyes. Future RCTs should assess changes in patient-reported outcomes (symptoms, cosmesis) and visual acuity, and evaluate effects of surgical variations.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Clearfield E, Hawkins BS, Kuo IC, et al. Conjunctival Autograft Versus Amniotic Membrane Transplantation for Treatment of Pterygium: Findings From a Cochrane Systematic Review. Am J Ophthalmol. 2017. PMID: 28734814. doi:10.1016/j.ajo.2017.07.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。